Antispasmodics Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1365571 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Antispasmodics Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antispasmodics Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antispasmodics Drugs Overall Market Size
    2.1 Global Antispasmodics Drugs Market Size: 2021 VS 2028
    2.2 Global Antispasmodics Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Antispasmodics Drugs Players in Global Market
    3.2 Top Global Antispasmodics Drugs Companies Ranked by Revenue
    3.3 Global Antispasmodics Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Antispasmodics Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Antispasmodics Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Antispasmodics Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Antispasmodics Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Antispasmodics Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Antispasmodics Drugs Market Size Markets, 2021 & 2028
        4.1.2 Oral
        4.1.3 Injectable
        4.1.4 Others
    4.2 By Type - Global Antispasmodics Drugs Revenue & Forecasts
        4.2.1 By Type - Global Antispasmodics Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Antispasmodics Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antispasmodics Drugs Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Special Clinic
        5.1.4 Home Care
        5.1.5 Others
    5.2 By Application - Global Antispasmodics Drugs Revenue & Forecasts
        5.2.1 By Application - Global Antispasmodics Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Antispasmodics Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Antispasmodics Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Antispasmodics Drugs Revenue & Forecasts
        6.2.1 By Region - Global Antispasmodics Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Antispasmodics Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Antispasmodics Drugs Revenue, 2017-2028
        6.3.2 US Antispasmodics Drugs Market Size, 2017-2028
        6.3.3 Canada Antispasmodics Drugs Market Size, 2017-2028
        6.3.4 Mexico Antispasmodics Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Antispasmodics Drugs Revenue, 2017-2028
        6.4.2 Germany Antispasmodics Drugs Market Size, 2017-2028
        6.4.3 France Antispasmodics Drugs Market Size, 2017-2028
        6.4.4 U.K. Antispasmodics Drugs Market Size, 2017-2028
        6.4.5 Italy Antispasmodics Drugs Market Size, 2017-2028
        6.4.6 Russia Antispasmodics Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Antispasmodics Drugs Market Size, 2017-2028
        6.4.8 Benelux Antispasmodics Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Antispasmodics Drugs Revenue, 2017-2028
        6.5.2 China Antispasmodics Drugs Market Size, 2017-2028
        6.5.3 Japan Antispasmodics Drugs Market Size, 2017-2028
        6.5.4 South Korea Antispasmodics Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Antispasmodics Drugs Market Size, 2017-2028
        6.5.6 India Antispasmodics Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Antispasmodics Drugs Revenue, 2017-2028
        6.6.2 Brazil Antispasmodics Drugs Market Size, 2017-2028
        6.6.3 Argentina Antispasmodics Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Antispasmodics Drugs Revenue, 2017-2028
        6.7.2 Turkey Antispasmodics Drugs Market Size, 2017-2028
        6.7.3 Israel Antispasmodics Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Antispasmodics Drugs Market Size, 2017-2028
        6.7.5 UAE Antispasmodics Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Allergan
        7.1.1 Allergan Corporate Summary
        7.1.2 Allergan Business Overview
        7.1.3 Allergan Antispasmodics Drugs Major Product Offerings
        7.1.4 Allergan Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.1.5 Allergan Key News
    7.2 Hikma Pharmaceuticals
        7.2.1 Hikma Pharmaceuticals Corporate Summary
        7.2.2 Hikma Pharmaceuticals Business Overview
        7.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Major Product Offerings
        7.2.4 Hikma Pharmaceuticals Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.2.5 Hikma Pharmaceuticals Key News
    7.3 Lannett
        7.3.1 Lannett Corporate Summary
        7.3.2 Lannett Business Overview
        7.3.3 Lannett Antispasmodics Drugs Major Product Offerings
        7.3.4 Lannett Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.3.5 Lannett Key News
    7.4 Mylan
        7.4.1 Mylan Corporate Summary
        7.4.2 Mylan Business Overview
        7.4.3 Mylan Antispasmodics Drugs Major Product Offerings
        7.4.4 Mylan Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.4.5 Mylan Key News
    7.5 Nexus Pharmaceuticals
        7.5.1 Nexus Pharmaceuticals Corporate Summary
        7.5.2 Nexus Pharmaceuticals Business Overview
        7.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Major Product Offerings
        7.5.4 Nexus Pharmaceuticals Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.5.5 Nexus Pharmaceuticals Key News
    7.6 Akorn
        7.6.1 Akorn Corporate Summary
        7.6.2 Akorn Business Overview
        7.6.3 Akorn Antispasmodics Drugs Major Product Offerings
        7.6.4 Akorn Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.6.5 Akorn Key News
    7.7 Aurobindo Pharma
        7.7.1 Aurobindo Pharma Corporate Summary
        7.7.2 Aurobindo Pharma Business Overview
        7.7.3 Aurobindo Pharma Antispasmodics Drugs Major Product Offerings
        7.7.4 Aurobindo Pharma Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.7.5 Aurobindo Pharma Key News
    7.8 Daiichi Sankyo
        7.8.1 Daiichi Sankyo Corporate Summary
        7.8.2 Daiichi Sankyo Business Overview
        7.8.3 Daiichi Sankyo Antispasmodics Drugs Major Product Offerings
        7.8.4 Daiichi Sankyo Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.8.5 Daiichi Sankyo Key News
    7.9 Fresenius Kabi
        7.9.1 Fresenius Kabi Corporate Summary
        7.9.2 Fresenius Kabi Business Overview
        7.9.3 Fresenius Kabi Antispasmodics Drugs Major Product Offerings
        7.9.4 Fresenius Kabi Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.9.5 Fresenius Kabi Key News
    7.10 Shanghai Fosun Pharmaceutical
        7.10.1 Shanghai Fosun Pharmaceutical Corporate Summary
        7.10.2 Shanghai Fosun Pharmaceutical Business Overview
        7.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Major Product Offerings
        7.10.4 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.10.5 Shanghai Fosun Pharmaceutical Key News
    7.11 SunGen Pharma
        7.11.1 SunGen Pharma Corporate Summary
        7.11.2 SunGen Pharma Business Overview
        7.11.3 SunGen Pharma Antispasmodics Drugs Major Product Offerings
        7.11.4 SunGen Pharma Antispasmodics Drugs Revenue in Global Market (2017-2022)
        7.11.5 SunGen Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Antispasmodics Drugs Market Opportunities & Trends in Global Market
    Table 2. Antispasmodics Drugs Market Drivers in Global Market
    Table 3. Antispasmodics Drugs Market Restraints in Global Market
    Table 4. Key Players of Antispasmodics Drugs in Global Market
    Table 5. Top Antispasmodics Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antispasmodics Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antispasmodics Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antispasmodics Drugs Product Type
    Table 9. List of Global Tier 1 Antispasmodics Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antispasmodics Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antispasmodics Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antispasmodics Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antispasmodics Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antispasmodics Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antispasmodics Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antispasmodics Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antispasmodics Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antispasmodics Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antispasmodics Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antispasmodics Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antispasmodics Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antispasmodics Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antispasmodics Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antispasmodics Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antispasmodics Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antispasmodics Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antispasmodics Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antispasmodics Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antispasmodics Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Allergan Corporate Summary
    Table 31. Allergan Antispasmodics Drugs Product Offerings
    Table 32. Allergan Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Hikma Pharmaceuticals Corporate Summary
    Table 34. Hikma Pharmaceuticals Antispasmodics Drugs Product Offerings
    Table 35. Hikma Pharmaceuticals Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Lannett Corporate Summary
    Table 37. Lannett Antispasmodics Drugs Product Offerings
    Table 38. Lannett Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Mylan Corporate Summary
    Table 40. Mylan Antispasmodics Drugs Product Offerings
    Table 41. Mylan Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Nexus Pharmaceuticals Corporate Summary
    Table 43. Nexus Pharmaceuticals Antispasmodics Drugs Product Offerings
    Table 44. Nexus Pharmaceuticals Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Akorn Corporate Summary
    Table 46. Akorn Antispasmodics Drugs Product Offerings
    Table 47. Akorn Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Aurobindo Pharma Corporate Summary
    Table 49. Aurobindo Pharma Antispasmodics Drugs Product Offerings
    Table 50. Aurobindo Pharma Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Daiichi Sankyo Corporate Summary
    Table 52. Daiichi Sankyo Antispasmodics Drugs Product Offerings
    Table 53. Daiichi Sankyo Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Fresenius Kabi Corporate Summary
    Table 55. Fresenius Kabi Antispasmodics Drugs Product Offerings
    Table 56. Fresenius Kabi Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Shanghai Fosun Pharmaceutical Corporate Summary
    Table 58. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product Offerings
    Table 59. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. SunGen Pharma Corporate Summary
    Table 61. SunGen Pharma Antispasmodics Drugs Product Offerings
    Table 62. SunGen Pharma Antispasmodics Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antispasmodics Drugs Segment by Type in 2021
    Figure 2. Antispasmodics Drugs Segment by Application in 2021
    Figure 3. Global Antispasmodics Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antispasmodics Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antispasmodics Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antispasmodics Drugs Revenue in 2021
    Figure 8. By Type - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 12. US Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 24. China Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antispasmodics Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antispasmodics Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Allergan Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Hikma Pharmaceuticals Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Lannett Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Mylan Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Nexus Pharmaceuticals Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Akorn Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Aurobindo Pharma Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Daiichi Sankyo Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Fresenius Kabi Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. SunGen Pharma Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Antispasmodics Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antispasmodics Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antispasmodics Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports